Hamilton Wealth »

Regeneron Pharmaceuticals shares owned by Hamilton Wealth

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Hamilton Wealth from 13F filings

Historical chart of Hamilton Wealth investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Hamilton Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Hamilton Wealth

Quarter filed Position value Share count Share price at filing
2023-12-31 $235k 268 878.29

More positions owned by Hamilton Wealth

Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard World Extended Dur (EDV)
Meta Platforms Cl A (META)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Global X Fds S&p 500 Covered (XYLD)
Walt Disney Company (DIS)
Vanguard World Fds Financials Etf (VFH)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr U.s. Med Dvc Etf (IHI)
Invesco Exchange Traded Fd T Water Res Etf (PHO)
Moderna (MRNA)
Pfizer (PFE)

View all positions for Hamilton Wealth

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals